Who owns ELI LILLY & Co (LL)? Elite investor 13F holders

16 tracked elite investors reported holding ELI LILLY & Co as of 2026-06-30, including GMO, Polen Capital Management, D.E. Shaw, Mairs & Power Funds, Jensen Investment Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

16 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
GMOELI LILLY & COSHARE2026-06-302026-08-13 00:00:00892337542.00 USD743966.000000SharesreduceOriginal filing
Polen Capital ManagementELI LILLY & COSHARE2026-06-302026-08-04 00:00:00799914391.00 USD666912.000000SharesreduceOriginal filing
D.E. ShawELI LILLY & COSHARE2026-06-302026-08-14 00:00:00595592559.00 USD496563.000000SharesreduceOriginal filing
Mairs & Power FundsELI LILLY & COSHARE2026-06-302026-08-14 00:00:00386371186.00 USD322129.000000SharesreduceOriginal filing
Jensen Investment ManagementELI LILLY & COSHARE2026-06-302026-08-07 00:00:00184394371.00 USD153735.000000SharesreduceOriginal filing
Tudor InvestmentELI LILLY & COSHARE2026-06-302026-08-14 00:00:0037044396.00 USD30885.000000SharesreduceOriginal filing
Bridgewater AssociatesELI LILLY & COSHARE2026-06-302026-08-14 00:00:00104377997.00 USD87023.000000SharesaddOriginal filing
Renaissance Technologies LLCELI LILLY & COSHARE2026-06-302026-08-13 00:00:0031294701.00 USD26091.000000SharesreduceOriginal filing
Dodge & Cox FundsELI LILLY & COSHARE2026-06-302026-08-13 00:00:0049486083.00 USD41258.000000SharesreduceOriginal filing
GAMCOELI LILLY & COSHARE2026-06-302026-08-12 00:00:0032836795.00 USD27377.000000SharesaddOriginal filing
Gotham Asset ManagementELI LILLY & COSHARE2026-06-302026-08-14 00:00:0026352677.00 USD21971.000000SharesaddOriginal filing
Duquesne Family OfficeELI LILLY & COSHARE2026-06-302026-08-14 00:00:0014849000.00 USD12380.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsELI LILLY & COSHARE2026-06-302026-08-14 00:00:003816589.00 USD3182.000000SharesaddOriginal filing
Oakmark FundsELI LILLY & COSHARE2026-06-302026-08-14 00:00:00516954.00 USD431.000000SharesreduceOriginal filing
Torray FundsELI LILLY & COSHARE2026-06-302026-07-30 00:00:00477373.00 USD398.000000SharesholdOriginal filing
Matrix Asset AdvisorsELI LILLY & COSHARE2026-06-302026-07-15 00:00:00372488.00 USD311.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown